We demonstrated that methotrexate play an inhibitory effect on rheumatoid arthritis swelling and inflammation by downregulating NF-κB and NLRP3/Caspase-1 pathways and potentially affecting the activity of caspase-1. This evidence concerns the gene CASP1 and rheumatoid arthritis.